MicroPort Orthopedics has launched its new Procotyl Prime Acetabular Cup System, following 510(k) clearance from the US Food and Drug Administration(FDA) in June.

Designed for total hip replacement surgery, Procotyl is a versatile system intended to support various surgical approaches such as modern and soft tissue.

The device is made of highly cross-linked polyethylene material to allow higher wear resistance while retaining mechanical properties.

MicroPort Orthopedics president Aurelio Sahagun said: “At MicroPort Orthopedics, we embrace the constant advance in orthopaedic medicine, and have a deep commitment to creating products that make patients’ lives better.

“The Procotyl Prime Acetabular Cup System, with its best-in-class features, is a great example of this commitment, as it not only strengthens our position as a leader in surgical joint replacement, but also complements our existing products and surgical approaches to help patients return to full function faster.”

"The result is a shell that is strong and flexible, has maximised poly thickness and robust pull-out strength, all while allowing the versatility of large head options in the smallest sizes."

Procotyl Prime Acetabular Cup System features BioFoam cancellous titanium shell material, metal and ceramic head options, and 46-68mm shell sizes.

Phoenix St Luke’s Medical Centre Orthopaedics Hip and Joint director Dr James Chow said: “We set out to design an implant optimised for highly cross-linked polyethylene and modern 3D fixation surfaces, allowing us to eliminate compromises.

“The result is a shell that is strong and flexible, has maximised poly thickness and robust pull-out strength, all while allowing the versatility of large head options in the smallest sizes.”

Founded in 2014 as a member of MicroPort Scientific, MicroPort Orthopedics produces hip and knee implants, and delivers them across more than 60 countries such as the US, EMEA, Japanese, Latin America, and China.